compound 5d [PMID: 25815150] [2322]
compound 5d [PMID: 25815150]
| SMILES |
N=C(N)NCCC[C@H](NC(=O)[C@@H]1CCCN1C(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1ccc(F)cc1)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)Cc1cccs1)C(=O)N[C@@H](CC(N)=O)C(N)=O |
| InChIKey |
TZCCKCLHNUSAMQ-DUGSHLAESA-N |
| Sequence |
None |
| HELM |
PEPTIDE1{[*C(=O)Cc1cccs1 |$_R2;;;;;;;;$|].W.[*C(=O)[C@H](Cc1ccc(cc1)F)N* |$_R2;;;;;;;;;;;;;_R1$|].R.P.R.N.[am]}$$$$ |
Chemical Properties
| Hydrogen bond acceptors |
11 |
| Hydrogen bond donors |
14 |
| Rotatable bonds |
27 |
| Log P |
-1.301 |
| Molecular weight (Da) |
1015.5 |
| Stereochemistry info |
unspecified |
Bioactivities
|
| Receptor |
Activity |
Source |
| Protein |
Gene |
Species |
Family |
Class |
Type |
Min |
Avg |
Max |
Database |
|
|
|
|
|
|
|
|
|
|
|
| Receptor |
Activity |
Source |
| Protein |
Gene |
Species |
Family |
Class |
Type |
Min |
Avg |
Max |
Database |
|
|
|
|
|
|
|
|
|
|
compound 5d [PMID: 25815150]
Drug properties
| Molecular type |
Peptide |
| Physiological/Surrogate |
Surrogate |
| Approved drug |
No |
Distribution across phases (no. indications)
Phase I
0
Phase II
0
Phase III
0
Phase IV
0
Compound is not listed as a drug.